2015
DOI: 10.1055/s-0034-1396240
|View full text |Cite
|
Sign up to set email alerts
|

Amelioration by Catalpol of Atherosclerotic Lesions in Hypercholesterolemic Rabbits

Abstract: The aim of the present study was to evaluate the effects of catalpol administration on atherosclerosis. Atherogenesis was induced by a high-cholesterol chow in male New Zealand White rabbits that were randomly assigned to receive atorvastatin (5 mg/kg/day), catalpol (5 mg/kg/day), or vehicle by oral gavage for 12 weeks. The rabbits were sacrificed after 12 weeks, and the thoracic aorta and serum were collected for further pathological and molecular biological analysis. Catalpol administration resulted in signi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 46 publications
1
20
0
Order By: Relevance
“…Catalpol significantly reduced TNF-α, soluble VCAM-1, ICAM-1, IL-6, and MCP-1 in the serum and reduced the levels of VCAM-1, MCP-1, MMP-9, TNF-α, NF-κB, and iNOS protein in aortic arch tissue. Additionally, catalpol reduced lipid peroxidation levels, and elevated antioxidant activity [71]. Catalpol may have a beneficial effect in stroke in view of its ability to protect against middle cerebral artery occlusion in rats; in this model catalpol showed a significant vasoprotective and angiogenic effect through stimulation of the JAK-STAT pathway [72].…”
Section: Vascular Protectionmentioning
confidence: 94%
See 1 more Smart Citation
“…Catalpol significantly reduced TNF-α, soluble VCAM-1, ICAM-1, IL-6, and MCP-1 in the serum and reduced the levels of VCAM-1, MCP-1, MMP-9, TNF-α, NF-κB, and iNOS protein in aortic arch tissue. Additionally, catalpol reduced lipid peroxidation levels, and elevated antioxidant activity [71]. Catalpol may have a beneficial effect in stroke in view of its ability to protect against middle cerebral artery occlusion in rats; in this model catalpol showed a significant vasoprotective and angiogenic effect through stimulation of the JAK-STAT pathway [72].…”
Section: Vascular Protectionmentioning
confidence: 94%
“…Catalpol (5 mg/kg daily p.o. for 12 weeks) reduced atherosclerotic lesions in rabbits fed a high cholesterol diet, this effect was accompanied by a marked reduction in circulating total cholesterol, triglycerides, and low-density lipoprotein cholesterol and an elevation in high-density lipid cholesterol [71]. Catalpol significantly reduced TNF-α, soluble VCAM-1, ICAM-1, IL-6, and MCP-1 in the serum and reduced the levels of VCAM-1, MCP-1, MMP-9, TNF-α, NF-κB, and iNOS protein in aortic arch tissue.…”
Section: Vascular Protectionmentioning
confidence: 96%
“…As in the examples quoted earlier, catalpol lowers the levels of total cholesterol, triglycerides, and low-density lipoproteins in blood serum and boosts the level of high-density lipoproteins. Furthermore, the reduction of TNF-α, Il-6, MCP-1, soluble VCAM-1, and soluble ICAM-1 levels in the serum was observed in a rabbit study [51]. Meanwhile, the depletion of VCAM-1, MCP-1, TNF-α, iNOS, matrix metalloproteinase-9, and NF-κB expression levels in the aortic arch was noticed.…”
Section: Iridoids In Fatty Liver Diseasementioning
confidence: 84%
“…The positive effects on lipids and atherosclerosis were also proven for other iridoids isolated from various plants. [24][25][26] Nevertheless, knowledge about the effects of loganic acid we found in cornelian cherry on living systems, especially on atherogenesis, is poor.…”
Section: Discussionmentioning
confidence: 99%